SAN MARCOS, Texas, Nov. 7, 2013 /PRNewswire/ -- Quantum
Materials Corp. (OTCQB:QTMM) announced today that it has provided
Tetrapod Quantum Dots (TQD) to an advanced medical device
manufacturer to optimize performance of an "engineered spectrum"
quantum dot-enabled light source to better provide useful data to
researchers and practitioners that has not been easily discernible
until now.
(Logo:
http://photos.prnewswire.com/prnh/20121120/DA16554LOGO)
David Doderer, Quantum Materials
Vice President of R&D, explained, "We are fulfilling specific
requests for tetrapod quantum dots, in this case, to
create tailored light for investigation of tissue.
Differences between healthy and suspect tissue often can be better
identified if the available fluorophores' color combination is
engineered for either true representation of color, or emphasized
in the visible spectrum depending on the tissue type. I think our
bespoke tetrapod quantum dots provide the depth of data necessary
to highlight subtle differences that researchers and healthcare
professionals need to efficiently understand disease and devise
effective treatments."
To achieve efficient healthcare in an increasingly demanding
marketplace, the ability to get actionable information is crucial.
Medical diagnostic assays currently count in the multi-millions per
year and per country, and differences in tissues types at the
cellular level are critically important for accuracy in
results. Conventional organic dyes and other types of
fluorophores are currently used for luminescence in assays by
researchers, but they have limitations sometimes preventing clear
distinctions in reading the data. Broad data sets can tend to
obscure patterns that might become clear by removing these
uncertainties.
Tetrapod quantum dots address this issue well for biochemical
detection and biomedical device application by providing a broad
array of colors, which translates to increased number of pieces in
the data set, and also precise tune-ability and stability for high
contrast and distinctive identification certainty. For
biochemical detection, most typically in a rapid assay that
provides a breadth of data in a single test kit, Quantum Materials
has begun conversations with biotech researchers and companies
needing narrow color emissions to provide clear identification when
identifying particular targets by attaching to the desired organism
or cell type when specifically functionalized.
As part of this effort, Quantum Materials is developing a
suitable TQD film for medical devices while maintaining consistency
in both uniformity and scalability. Quantum Materials believes this
technology, one of several under review, could also successfully
translate into Tetrapod Quantum Dot film applications such as
general light applications, electronic displays and quantum dot
solar cells.
About Quantum Materials Corp.
Quantum Materials Corp. manufactures Tetrapod Quantum Dots for
use in medical, display, solar energy and lighting applications
through patent pending continuous-flow production process.
Quantum dot semiconductors enable a new level of engineered
performance in a wide array of established consumer and industrial
products. QMC's volume manufacturing methods enable consistent QD
quality and scalable cost reductions to drive innovative discovery
to commercial success. (http://www.qmcdots.com)
Safe Harbor statement under the Private Securities Litigation
Reform Act of 1995
This press release contains forward-looking statements that
involve risks and uncertainties concerning business, products, and
financial results. Actual results may differ materially from the
results predicted. More information about potential risk factors
that could affect our business, products, and financial results are
included in our annual report and in reports subsequently filed
with the Securities and Exchange Commission ("SEC"). All documents
are available through the SEC's EDGAR System at http://www.sec.gov/
or www.QMCdots.com. We hereby disclaim any obligation to publicly
update the information provided above, including forward-looking
statements, to reflect subsequent events or circumstances.
Contact:
Art Lamstein
Director of Marketing
Quantum Materials Corp.
415.609.4969
artlamstein@QMCdots.com
Media:
Rich Schineller
941.780.8100
rich@prmgt.com
SOURCE Quantum Materials Corporation